Healio

Second-generation IBS blood test available for commercial distribution

PHILADELPHIA – Gemelli Biotech, in cooperation with the Medically Associated Science and Technology Program at Cedars-Sinai, announced the availability of ibs-smart, a blood test for the diagnosis of ...
FiercePharma

Vexing IBS-D spokescharacter 'Irritabelle' headlines Allergan's Viberzi ad push

She's an irritating, yet oddly captivating, redhead in a flesh-colored unitard with screen-printed intestines on her stomach. No, it's not your crazy cousin's latest Halloween getup, but the newest ...

Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS

Publication details large multicenter clinical trial demonstrating significant reductions in IBS symptoms through inFoods IBS guided dietary ...
Healio

Ironwood, Allergan to co-promote Viberzi for IBS-D in US

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Ironwood Pharmaceuticals today announced ...
Business Wire

Ironwood and Allergan Enter Agreement to Co-Promote VIBERZI for Irritable Bowel Syndrome with Diarrhea (IBS-D) in the U.S.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today an agreement with Allergan plc for the U.S. co-promotion of VIBERZI™ (eluxadoline), Allergan’s new ...
WRIC

Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer

IRVINE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced plans to launch its InFoods ® IBS test before calendar year end. The test will be ...
Nasdaq

Biomerica Inc. Appoints Scott Madel as Chief Commercial Officer to Drive Growth of inFoods® IBS

Biomerica Inc. has appointed Scott Madel as Chief Commercial Officer, bringing over 20 years of experience in revenue growth and commercialization in the healthcare and diagnostics sectors. Madel ...
Becker's ASC

Biomerica hires new chief commercial officer ahead of IBS test launch

Bioamerica has hired Robert Carlson as its new chief commercial officer as it prepares to launch the new InFoods IBS test before the end of the year. The test is currently in clinical trials at ...
FiercePharma

Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults

-First in class treatment for IBS-D treats hallmark symptoms of IBS-D; abdominal pain and diarrhea - IBS-D can be debilitating, affecting up to 15 million Americans, and there are limited therapeutic.
Healthline

Your guide to understanding Irritable Bowel Syndrome With Diarrhea (IBS-D)

IBS-D is a subtype of IBS characterized by diarrhea. The triggers can vary among different people, but knowing finding out your potential triggers can help improve your daily life. Lifestyle ...
WebMD

Medication and Other Treatment Options for IBS-D

Irritable bowel syndrome (IBS) can be tough to live with. How tough? A 2015 survey from the American Gastroenterological Association found that 47% of people with IBS would give up their cell phone ...